Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.

Basic & clinical pharmacology & toxicology - 1 Jan 2006

Justesen Ulrik Stenz

Abstract excerpt

Treatment with antiretroviral drugs such as the HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors have contributed to the improvement of life of many HIV-infected patients in recent years, but antiretroviral therapy is not without problems. In some patients, treatment is not effective and suppression of viral replication is not achieved. Other patients experience toxicity and have to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Patient Compliance

Share to Randomized Controlled Trials as Topic

Share to Virus Replication

Source

Identifiers

PMID: 16433887
DOI: 10.1111/j.1742-7843.2006.pto_246.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.PMID 16433887Read ↗

Therapeutic drug monitoring of antiretroviral therapy.Semantic proximity Read ↗

Therapeutic drug monitoring in highly active antiretroviral therapy.Semantic proximity Read ↗

Human immunodeficiency virus drug resistance testing: state of the art in genotypic and phenotypic testing of antiretrovirals.Semantic proximity Read ↗

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patientsSemantic proximity Read ↗

Recent advances in antiretroviral therapy and HIV infection monitoring.Semantic proximity Read ↗

Antiretroviral Therapy in the ClinicSemantic proximity Read ↗

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?Semantic proximity Read ↗

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.Semantic proximity Read ↗

Methods for integration of pharmacokinetic and phenotypic information in the treatment of infection with human immunodeficiency virus.Semantic proximity Read ↗

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.Semantic proximity Read ↗

Principles and practice of HIV-protease inhibitor pharmacoenhancement.Semantic proximity Read ↗

Antiretroviral therapy 2006: pharmacology, applications, and special situations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.